Aurobindo Pharma consolidated PAT up 39.3% YoY
Aurobindo Pharma consolidated PAT stood at Rs 563 cr vs Rs 404 cr, up 39.3% YoY.
READ MORE:
Other Results Videos
Maruti Suzuki Q3 Results: PAT jumps 33% YoY to Rs 3,207 cr; revenue up 15%
L&T Q3 Results: Net profit rises 16% YoY to Rs 2,947 cr; revenue up 19%
L&T Q3 results Preview: Here's what to expect from infrastructure major
Dr Reddy's Q3 Results: Profit meets estimates, jumps 11% YoY to Rs 1,379 cr; revenue up 7%
ITC Q3 Results: Profit rises 6% YoY to Rs 5,335 cr; co declares Rs 6.25/share dividend
